Dare Bioscience
(NASDAQ:DARE)
$0.3099
0.0146[4.94%]
Last update: 9:25AM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Dare Bioscience Stock (NASDAQ:DARE), Quotes and News Summary

Dare Bioscience Stock (NASDAQ: DARE) stock price, news, charts, stock research, profile.

Open$0.318
Close-
Volume / Avg.301.167K / 436.350K
Day Range0.294 - 0.319
52 Wk Range0.270 - 1.100
Market Cap$31.170M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
31
Short Interest
0.24%
Days to Cover1

Recent News

First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks
Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of awareness. ARPA-H Sprint for Women's Health aims to promote innovative solutions.
Vandana Singh
Daré Bioscience Highlights Efficacy Data From Treatment Candidate For Painful Menstruation
Daré Bioscience Inc (NASDAQ: DARE) announced topline results from the Phase 1 DARE-PDM1-001 study evaluating the pharmacokinetics (PK), safety, and exploratory efficacy of DARE-PDM1 an investigational product designed to deliver diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), vaginall
Vandana Singh
FDA Gives Nod To Daré Bioscience's Trial Of Non-Hormonal Treatment For Dyspareunia, Seeks Additional Funding
Daré Bioscience Inc (NASDAQ: DARE) announced that the FDA has cleared its investigational new drug (IND) application for DARE-VVA1 as a non-hormonal treatment option for moderate to severe dyspareunia, a symptom of VVA 
Vandana Singh
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Nov 23
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Dare Bioscience Inc
Sector
Health Care
Industry
Pharmaceuticals
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for wo...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
DARE
CPIX

FAQ

Q

How do I buy Dare Bioscience (DARE) stock?

A

You can purchase shares of Dare Bioscience (NASDAQ: DARE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Dare Bioscience's (DARE) competitors?

A

Other companies in Dare Bioscience’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), SCYNEXIS (NASDAQ:SCYX) and Jaguar Health (NASDAQ:JAGX).

Q

What is the target price for Dare Bioscience (DARE) stock?

A

The latest price target for Dare Bioscience (NASDAQ: DARE) was reported by Brookline Capital on Wednesday, April 17, 2024. The analyst firm set a price target for 0.00 expecting DARE to fall to within 12 months (a possible -100.00% downside). 8 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Dare Bioscience (DARE)?

A

The stock price for Dare Bioscience (NASDAQ: DARE) is $0.2939 last updated Today at April 23, 2024 at 3:23 PM EDT.

Q

Does Dare Bioscience (DARE) pay a dividend?

A

There are no upcoming dividends for Dare Bioscience.

Q

When is Dare Bioscience (NASDAQ:DARE) reporting earnings?

A

Dare Bioscience’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Q

Is Dare Bioscience (DARE) going to split?

A

There is no upcoming split for Dare Bioscience.

Q

What sector and industry does Dare Bioscience (DARE) operate in?

A

Dare Bioscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch